top of page
The Professional Network for Healthcare Experts
FDA approves Lyrfigtu for previously treated FGFR2-altered cholangiocarcinoma
The FDA has approved Lyrfigtu for adults with previously treated FGFR2-altered cholangiocarcinoma, adding a new targeted therapy for this molecularly defined group of bile duct cancers.
nuaxia
Sep 241 min read
Renalytix and Quest Diagnostics partner to expand kidneyintelX.dkd testing across the US
Renalytix has signed a multi-year agreement with Quest Diagnostics to expand US access to its kidneyintelX.dkd blood test for patients with type 2 diabetes and chronic kidney disease.
nuaxia
Sep 21 min read
McKesson agrees $2.25 billion acquisition of Precision Medicine Group to expand biopharma services
The acquisition adds clinical research, biomarker, laboratory, market access and commercialisation capabilities to McKesson’s Oncology & Multispecialty business, extending its services across the drug-development pathway.
nuaxia
Aug 262 min read
HanchorBio partners with Taiwan Cancer Moonshot team to advance precision immunotherapy development
The collaboration combines HanchorBio's immuno-oncology platform with Taiwan's national precision oncology programme to support biomarker-driven clinical development and translational research.
nuaxia
Aug 132 min read
bottom of page